Affimed to Present at Upcoming Investor Conferences

On August 26, 2021 Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, reported that management will present and host one-on-one meetings at the following investor conferences during the month of September 2021 (Press release, Affimed, AUG 26, 2021, View Source [SID1234586934]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 16th Annual BioPharma Virtual Conference (September 8-10, 2021)
Date: Wednesday, September 8, 2021
No presentation, only one-on-one meetings
Location: Virtual

2021 Wells Fargo Virtual Healthcare Conference (September 9-10, 2021)
Date: Thursday, September 9, 2021
Presentation Time: 8:00 a.m. Eastern Time
Webcast: View Source
Location: Virtual

Morgan Stanley 19th Annual Global Healthcare Conference (September 9-15, 2021)
Date: Friday, September 10, 2021
No Presentation, only one-on-one meetings
Location: Virtual

Cantor Fitzgerald Virtual Global Healthcare Conference 2021 (September 27-30, 2021)
Date: Monday, September 27, 2021
Presentation Time: 10:00 a.m. Eastern Time
Webcast: View Source
Location: Virtual

For more information or to schedule a one-on-one meeting with Affimed’s management, please contact your conference representative or Alex Fudukidis via email at [email protected] or phone at +1 (917) 436-8102.